Olvidé mi contraseña
Asóciese a SIIC en Internet para utilizar sin límites tanto siicsalud como la totalidad de los servicios bibliográficos de la institución.
Lectura recomendada:
Tacrolimus Preserves Renal Function better than Cyclosporin at 10 Years Long Term Results of a Randomissed Controlled Trial
http://www.atcmeeting.org/2009/index.cfm,
Lectura recomendada:
Rejection Characteristics of 200 Living Donor Kidney Transplants Using Alemtuzumab Induction and Tacrolimus Monotherapy: 4 Year Follow-Up
http://www.atcmeeting.org/2009/index.cfm,
Lectura recomendada:
Excellent Efficacy and Renal Function in Liver Recipients with Tacrolimus Once-Daily Prolonged Release: 2-Year Follow-Up
http://www.atcmeeting.org/2009/index.cfm,
Lectura recomendada:
Improved Growth in Pediatric Kidney Recipients after early Steroid Withdrawal: Daclizumab, Tacrolimus (TAC) and Mycophenolate Mofetil (MMF) versus TAC, MMF and Steroids (TWIST Study)
http://www.atcmeeting.org/2009/index.cfm,
Lectura recomendada:
In the Novo Kidney Transplant Recipients Higher Dosis of Advagraf Compared to Prograf are Needed to Get Therapeutic Levels
http://www.atcmeeting.org/2009/index.cfm,
Lectura recomendada:
Conversion of Stable Kidney Transplant Recipients from Tacrolimus Twice a Day to Once-Daily Formulation
http://www.atcmeeting.org/2009/index.cfm,
Lectura recomendada:
PK Modelling and Development of Bayesian Estimators in Kidney Transplant Patients Receiving Once-Daily Tacrolimus (ADVAGRAF)
http://www.atcmeeting.org/2009/index.cfm,
Lectura recomendada:
A Phase III, Randomized, Open-Label, Comparative, Multicenter Study to Assess the Safety and Efficacy of Prograf (Tacrolimus) and Extended Release (XL) Tacrolimus in Asian De Novo Kidney Transplants from Living Donors: 6 Month Results
http://www.atcmeeting.org/2009/index.cfm,
Lectura recomendada:
Long-Term Renal Function is Maintained in Kidney Recipients Treated with Once-Daily Prolonged-Release Tacrolimus: 2-Year Follow-Up
http://www.atcmeeting.org/2009/index.cfm,
Lectura recomendada:
Renal Function and Safety in Stable Kidney Recipients Converted from Tacrolimus Twice Daily to a Once-Daily Formulation
http://www.atcmeeting.org/2009/index.cfm,
Lectura recomendada:
Renal Function and Safety Post-Conversion from Twice-Daily to Once-Daily Tacrolimus: A Multicenter, Crossover Study in Liver Transplant Recipients
http://www.atcmeeting.org/2009/index.cfm,
Lectura recomendada:
Excellent Efficacy and Safety with Once-Daily Prolonged-Release Tacrolimus (Advagraf®) in Kidney Transplant Patients
Congreso Europeo de Trasplante - París 2009,
Lectura recomendada:
Sublingual Tacrolimus as an Alternative to Intravenous Route in Thoracic Organ Transplantation
Congreso Europeo de Trasplante - París 2009,
Lectura recomendada:
Tacrolimus (TAC) Monotherapy in Liver Transplantation (LT): One-Year Results of a Prospective, Randomized, Double-Blinded Placebo-Controlled Study
Congreso Europeo de Trasplante - París 2009,
Lectura recomendada:
Conversion from Prograf to Advagraf in Adolescents with Normal Graft Function after Liver Transplantation
Congreso Europeo de Trasplante - París 2009,
Lectura recomendada:
Excellent Efficacy and Renal Function in Liver Recipients with Once-Daily Prolonged-Release Tacrolimus (Advagraf®)
Congreso Europeo de Trasplante - París 2009,
Lectura recomendada:
Renal Function and Safety are Well-Maintained after Conversion from Twice-Daily Prograf® to Once-Daily Advagraf® in Stable Kidney Transplant Patients: A Phase IIIB Study
Congreso Europeo de Trasplante - París 2009,
Lectura recomendada:
Conversion from Twice-Daily Prograf to Once-Daily Advagraf is Straightforward in Stable Liver Transplant Recipients
Congreso Europeo de Trasplante - París 2009,